Effective silencing of adhesion molecules on venous endothelial cells for protection of venous bypass grafts

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 5, 2011, Pages 1241-1247

  Walker, Tobias ^a   Müller, Isabelle ^a   Raabe, Claudia ^a   Nohe, Boris ^a   Zanke, Christof ^a   Ziemer, Gerhard ^a   Wendel, Hans Peter ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

CABG; Endothelium; Gene therapy; Venous grafts

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; GRAFT PATENCY; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; SHEAR STRESS; VASCULAR ENDOTHELIUM; VEIN BYPASS;

CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; CORONARY ARTERY BYPASS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE SILENCING; GENE THERAPY; HUMANS; NEUTROPHILS; RNA, SMALL INTERFERING; SAPHENOUS VEIN; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR PATENCY;

EID: 80053965671     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.01.076     Document Type: Article

References (22)

1. Motwani J.G., Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998, 97:916-931.
2. Angelini G.D., Jeremy J.Y. Towards the treatment of saphenous vein bypass graft failure - a perspective of the Bristol Heart Institute. Biorheology 2002, 39:491-499.
3. Schachner T. Pharmacologic inhibition of vein graft neointimal hyperplasia. J Thorac Cardiovasc Surg 2006, 131:1065-1072.
4. Chello M., Mastroroberto P., Frati G., Patti G., D'Ambrosio A., Di Sciascio G., Covino E. Pressure distension stimulates the expression of endothelial adhesion molecules in the human saphenous vein graft. Ann Thorac Surg 2003, 76:453-458.
5. Crook M.F., Newby A.C., Southgate K.M. Expression of intercellular adhesion molecules in human saphenous veins: effects of inflammatory cytokines and neointima formation in culture. Atherosclerosis 2000, 150:33-41.
6. Shuhaiber J.H., Evans A.N., Massad M.G., Geha A.S. Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery. Eur J Cardiothorac Surg 2002, 22:387-396.
7. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170:191-203.
8. Vallely M.P., Bannon P.G., Hughes C.F., Kritharides L. Endothelial expression of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 is suppressed by postbypass plasma containing increased soluble intercellular adhesion molecule 1 and vascular cell adhesion molecule 1. J Thorac Cardiovasc Surg 2002, 124:758-767.
9. Walker T., Wendel H.P., Tetzloff L., Raabe C., Heidenreich O., Simon P., Scheule A.M., Ziemer G. Inhibition of adhesion molecule expression on human venous endothelial cells by non-viral siRNA transfection. J Cell Mol Med 2007, 11:139-147.
10. Walker T., Wendel H.P., Tetzloff L., Heidenreich O., Ziemer G. Suppression of ICAM-1 in human venous endothelial cells by small interfering RNAs. Eur J Cardiothorac Surg 2005, 28:816-820.
11. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973, 52:2745-2756.
12. Falk V. The 'real world' asks for coronary artery bypass grafting. Eur J Cardiothorac Surg 2009, 36:609-610.
13. Tatoulis J., Buxton B.F., Fuller J.A., Meswani M., Theodore S., Powar N., Wynne R. Long-term patency of 1108 radial arterial-coronary angiograms over 10 years. Ann Thorac Surg 2009, 88:23-29.
14. Possati G., Gaudino M., Prati F., Alessandrini F., Trani C., Glieca F., Mazzari M.A., Luciani N., Schiavoni G. Long-term results of the radial artery used for myocardial revascularization. Circulation 2003, 108:1350-1354.
15. Legare J.F., Buth K.J., Sullivan J.A., Hirsch G.M. Composite arterial grafts versus conventional grafting for coronary artery bypass grafting. J Thorac Cardiovasc Surg 2004, 127:160-166.
16. Khot U.N., Friedman D.T., Pettersson G., Smedira N.G., Li J., Ellis S.G. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation 2004, 109:2086-2091.
17. Hayward P.A., Gordon I.R., Hare D.L., Matalanis G., Horrigan M.L., Rosalion A., Buxton B.F. Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: results from the Radial Artery Patency and Clinical Outcomes trial. J Thorac Cardiovasc Surg 2010, 139:60-65.
18. Maniar H.S., Sundt T.M., Barner H.B., Prasad S.M., Peterson L., Absi T., Moustakidis P. Effect of target stenosis and location on radial artery graft patency. J Thorac Cardiovasc Surg 2002, 123:45-52.
19. Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 1992, 86:723-729.
20. Nesterova M., Cho-Chung Y.S. Killing the messenger: antisense DNA and siRNA. Curr Drug Targets 2004, 5:683-689.
21. Walker T., Wendel H.P., Raabe C., Wiechnik P., Spranger L., Heidenreich O., Scheule A.M., Nordheim A., Ziemer G. Graft protection in bypass surgery: siRNA-mediated silencing of adhesion molecules. Oligonucleotides 2009, 19:15-21.
22. Nohe B., Ries R., Ploppa A., Zanke C., Eichner M., Unertl K., Dieterich H.J. Effects of intraoperative blood salvage on leukocyte recruitment to the endothelium. Anesthesiology 2005, 102:300-307.